2020
DOI: 10.1186/s12984-020-00684-4
|View full text |Cite
|
Sign up to set email alerts
|

Role of data measurement characteristics in the accurate detection of Parkinson’s disease symptoms using wearable sensors

Abstract: Background: Parkinson's disease (PD) is a progressive neurological disease, with characteristic motor symptoms such as tremor and bradykinesia. There is a growing interest to continuously monitor these and other symptoms through body-worn sensor technology. However, limited battery life and memory capacity hinder the potential for continuous, long-term monitoring with these devices. There is little information available on the relative value of adding sensors, increasing sampling rate, or computing complex sig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
75
1
8

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(93 citation statements)
references
References 40 publications
3
75
1
8
Order By: Relevance
“…Parkinsonism has typically been measured by the UPDRS Part 3 or MDS-UPDRS Part 3, but these clinical measurements do not fully capture the sensitivity and type of motor symptoms (e.g., gait, balance, falls) in LBDs or everyday motor function at home. Opportunities to assess motor features and response to intervention in broader, more continuous, and real-life environments may include use of quantitative measures and remote assessment with wearable sensor technology [ 49 , 50 ].…”
Section: Optimizing Clinical Trial Design In Lbd (Table 2 mentioning
confidence: 99%
“…Parkinsonism has typically been measured by the UPDRS Part 3 or MDS-UPDRS Part 3, but these clinical measurements do not fully capture the sensitivity and type of motor symptoms (e.g., gait, balance, falls) in LBDs or everyday motor function at home. Opportunities to assess motor features and response to intervention in broader, more continuous, and real-life environments may include use of quantitative measures and remote assessment with wearable sensor technology [ 49 , 50 ].…”
Section: Optimizing Clinical Trial Design In Lbd (Table 2 mentioning
confidence: 99%
“…The human gait is also considered as biometric property, tracking physical activity and periodic analysis of it can lead to detection of any abnormal patterns such as sudden tremors that are precursor of various diseases like Parkinson's and Alzheimer's disease. Hence, these mechanical sensors can contribute towards early detection of such fatal diseases [117]. Moreover, these sensors also have potential applications in rehabilitation, sports training, and prothesis [118].…”
Section: Mechanical Sensorsmentioning
confidence: 99%
“…The types of sensors and devices were used to capture hand movements with nine-axis inertial measurement unit (IMU), acceleration, pressure and bending sensors, electromyography, magnetoencephalography (MEG), functional magnetic resonance imaging (fMRI), leap motion, virtual reality (VR), motion capture, and tablets [ 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 ].…”
Section: Introductionmentioning
confidence: 99%
“…Based on the data, they assessed the CSM patient’s hand dexterity [ 39 ]. Moreover, other studies have combined a smartwatch with a flexible hand-mounted sensor (with built-in triaxial acceleration and gyroscopes) to detect tremor symptoms in Parkinson’s disease [ 40 ], an infrared imaging device [ 41 ], a rehabilitation robot [ 42 ], and other devices for evaluating hand dexterity [ 43 , 44 ].…”
Section: Introductionmentioning
confidence: 99%